Toyota Teams with Tencent, Nissan Joins Forces with Baidu in China AI Drive 
Vaping now more common than smoking among young people – and the risks go beyond lung and brain damage 
Mercedes-Benz to Release Luxury Electric Van in China 
The hidden racist history of hair loss 
Elon Musk says ketamine can get you out of a ‘negative frame of mind’. What does the research say? 
Shiba Inu Announces Shibarium Hardfork: New Capabilities Teased, SHIB Price Jumps 3.2% 
Half our colleagues suffer pain and discomfort from periods. But they’re still a taboo subject at work 
Joe Biden Proposes Record 44.6% Capital Gains Tax in Latest Budget Plan That May Favor Cryptocurrencies 
DeepL Unleashes AI-Powered Tool for Business Writing 
Post-Halving Surge: Standard Chartered Predicts Bitcoin to Hit $150K on Reduced Market Leverage 
Banning TikTok won’t solve social media’s foreign influence, teen harm and data privacy problems 
Study links microplastics with human health problems – but there’s still a lot we don’t know 
Male baldness is often trivialised – our research shows it should be taken seriously 
Our laser technique can tell apart elephant and mammoth ivory – here’s how it may disrupt the ivory trade 
Arthur Hayes Predicts Major Bullish Crypto Market Recovery Signal From US Treasury Department 
Honey is said to help with hay fever symptoms – here’s what the research says about this claim 
Eye infections might seem like a minor complaint – but in some cases they can cause blindness and even death 
A scientist from the University of Massachusetts Medical School recently found a way to improve photodynamic therapy, which basically makes use of specific light molecules to target cancer tumors. This is a relatively new discovery in the medical industry, but it is fast getting traction thanks to the multitude of potential applications.
Gang Han, Ph.D. is the one who designed the new way to take advantage of photodynamic therapy to improve upon it along with his team, Phys.org reports. Trained in biochemistry & molecular pharmacology, Han is an associate professor at the university.
He and his team explained how the carbazole-substituted BODIPY (Car-BDP) can vastly improve the results of photodynamic therapy thanks to its NIR absorption band. Since its singlet oxygen quantum yield is exceedingly high, it leads to some unique results.
"This study signals a major step forward in photodynamic therapy by developing a new class of NIR-absorbing biodegradable organic nanoparticles for a highly effective targeting and treatment of deep-tissue tumors," Han said.
The results of the study were posted on the Journal of the American Chemical Society, where Han explains that after using the PLA–PEG-FA, which is a highly biodegradable polymer to encapsulate Car-BDP, the compound formed nanoparticles that possessed small, uniformed, organic, and water-soluble properties and is able to target tumors.
This helps overcome one of the bigger challenges that stop the wider adoption of photodynamic therapy, which is how shallow the penetration to tissue is right now. Normally, this is addressed via the introduction of drugs that are non-toxic and sensitive to light. Once the drug is inside the body, a laser is tuned with the molecules of the substances in the drug, which then targets the tumor.
Han and his team are proposing to make the whole thing simpler using Car-BDP and pairing it with a lamp light that has low power density. The molecules released by this method can be tracked as well, which makes monitoring which tumors have been targeted much easier.
